Evaluation of Δ9-tetrahydrocannabinol detection using DrugWipe5S® screening and oral fluid quantification after Quantisal™ collection for roadside drug detection via a controlled study with chronic cannabis users

Drug Testing and Analysis

Volumn 7, Issue 3, 2015, Pages 178-186

  Wille, Sarah M R ^a   Di Fazio, Vincent ^a   Toennes, Stefan W ^b   van Wel, Janelle H P ^c   Ramaekers, Johannes G ^c   Samyn, Nele ^a  

^a National Institute of Criminalistics and Criminology   (Belgium)

^b GOETHE UNIVERSITY   (Germany)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Cut off; Oral fluid collection; Roadside drug screening; Saliva; 9 tetrahydrocannabinol

Indexed keywords

CONTROLLED DRUG DELIVERY; DRUG PRODUCTS; GAS CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; SCREENING; SMOKE;

CUT-OFF; DRIVING UNDER THE INFLUENCE; DRUG DETECTION; DRUG-SCREENING; ORAL FLUID COLLECTION; ORAL FLUIDS; ROADSIDE DRUG SCREENING; SALIVA; SCREENING DEVICES; Δ9-TETRAHYDROCANNABINOL;

ROADSIDES;

DRONABINOL; PLACEBO; CANNABINOID RECEPTOR AGONIST;

ADULT; ARTICLE; BLOOD SAMPLING; CANNABIS ADDICTION; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DETERMINATION; DRUG RAPID TEST; DRUG SCREENING; HUMAN; INHALATION; LIQUID; ORAL FLUID; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SERUM; SMOKING; TANDEM MASS SPECTROMETRY; TEST STRIP; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; VAPORIZER; ADOLESCENT; BLOOD; CANNABIS SMOKING; CHEMISTRY; EUROPE; EVALUATION STUDY; MASS FRAGMENTOGRAPHY; PROCEDURES; SALIVA; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE; YOUNG ADULT;

ADOLESCENT; ADULT; CANNABINOID RECEPTOR AGONISTS; DOUBLE-BLIND METHOD; DRONABINOL; EUROPE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MARIJUANA SMOKING; SALIVA; SENSITIVITY AND SPECIFICITY; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 84924759227     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1660     Document Type: Article

References (36)

1. Belgian Parliament. Wet tot invoering van speekseltesten op drugs in het verkeer. Belgisch Staatsblad/Moniteur Belge, 31 July, Brussels, 2010.
2. French Parliament. Relative à la conduite sous l'influence de substances ou plantes classes comme stupéfiants, 3 February, Paris, 2003.
3. Parliament of Victoria. Road Safety (drug driving) Act 111/2003, Victoria, 2003.
4. S.W. Toennes, G.F. Kauert, S. Steinmeyer, M.R. Moeller. Driving under the influence of drugs - evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms. Forensic Sci. Int. 2005, 152, 149.
5. A. Verstraete, E. Raes. Rosita-2 Project, Final Report. Academia Press, Ghent, 2006.
6. T. Blencowe, A. Pehrsson, P. Lillsunde. Analytical evaluation of oral fluid screening devices and preceding selection procedures. Available at: http://www.druid-project.eu/nn_107548/Druid/EN/deliveraleslist/downloads/Deliverable__3__2__2, templateId=raw, property=publicationFile.pdf/Deliverable_3_2_2.pdf [4 June 2013].
7. N.A. Desrosiers, D. Lee, D.M. Schwope, G. Milman, A.J. Barnes, D.A. Gorelick, M.A. Huestis. On-site test for cannabinoids in oral fluid. Clin. Chem. 2012, 58, 1418.
8. T. Blencowe, A. Pehrsson, P. Lillsunde, K. Vimpari, S. Houwing, B. Smink, R. Mathijssen, T. Van der Linden, S.A. Legrand, K. Pil, A. Verstraete. An analytical evaluation of eight on-site oral fluid drug screening devices using laboratory confirmation results from oral fluid. Forensic Sci. Int. 2011, 208, 173.
9. S. Vanstechelman, C. Isalberti, T. Van der Linden, K. Pil, S.A. Legrand, A.G. Verstraete. Analytical evaluation of four on-site oral fluid drug testing devices. J. Anal. Toxicol. 2012, 36, 136.
10. S.M. Wille, N. Samyn, M. Ramírez-Fernández, G. De Boeck. Evaluation of on-site oral fluid screening using Drugwipe-5(+), RapidSTAT and Drug Test 5000 for the detection of drugs of abuse in drivers. Forensic Sci. Int. 2010, 198, 2.
11. J.K. Aps, L.C. Martens. Review: The physiology of saliva and transfer of drugs into saliva. Forensic Sci. Int. 2005, 150, 119.
12. K. Langel, C. Engblom, A. Pehrsson, T. Gunnar, K. Ariniemi, P. Lillsunde. Drug testing in oral fluid-evaluation of sample collection devices. J. Anal. Toxicol. 2008, 32, 393.
13. S.M. Wille, E. Raes, P. Lillsunde, T. Gunnar, M. Laloup, N. Samyn, A.S. Christopherssen, M.R. Moeller, K.P. Hammer, A.G. Verstraete. Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of driving under the influence of drugs. Ther. Drug Monit. 2009, 31, 511.
14. J.G. Ramaekers, G. Kauert, P. van Ruitenbeek, E.L. Theunissen, E. Schneider, M.R. Moeller. High-potency marijuana impairs executive function and inhibitory motor control. Neuropsychopharmacol. 2006, 31, 2296.
15. J.G. Ramaekers, M.R. Moeller, P. van Ruitenbeek, E.L. Theunissen, E. Schneider, G. Kauert. Cognition and motor control as a function of delta9-THC concentration in serum and oral fluid: Limits of impairment. Drug Alcohol Depend. 2006, 85, 114.
16. S.W. Toennes, K. Schneider, C. Wunder, G.F. Kauert, M.R. Moeller, E.L. Theunissen, J.G. Ramaekers. Influence of ethanol on the pharmacokinetic properties of Delta9-tetrahydrocannabinol in oral fluid. J. Anal. Toxicol. 2013, 37, 152.
17. S.W. Toennes, J.G. Ramaekers, E.L. Theunissen, M.R. Moeller, G.F. Kauert. Comparison of cannabinoid pharmacokinetic properties in occasional and heavy users smoking a marijuana or placebo joint. J. Anal. Toxicol. 2008, 32, 470.
18. ® collector. Ther. Drug Monit. 2013, 35, 101.
19. A. Hoffmann-La Roche. Roche Lexikon Medizin: Das grosse deutschsprachige Lexikon der Medizin. Urban & Fisher, Stuttgart, 2003.
20. H. Gjerde, P.T. Normann, A.S. Christophersen. The prevalence of alcohol and drugs in sampled oral fluid is related to sample volume. J. Anal. Toxicol. 2010, 34, 416.
21. J. Fischedick, F. Van der Kooy, R. Verpoorte. Cannabinoid receptor 1 binding activity and quantitative analysis of cannabis sativa L. smoke and vapor. Chem. Pharm. Bull. 2010, 58, 201.
22. L. Zuurman, C. Roy, R.C. Schoemaker, A. Hazekamp, J. den Hartigh, J.C. Bender, R. Verpoorte, J.L. Pinquier, A.F. Cohen, J.M.A. van Gerven. Effect of intrapulmonary tetrahydrocannabinol administration in humans. J. Psychochparmacol. 2008, 22, 707.
23. B. Pomahacova, F. Van der Kooy, R. Verpoorte. Cannabis smoke condensate III: The cannabinoid content of vaporised Cannabis sativa. Inhalation Toxicol. 2009, 21, 1108.
24. W.M. Bosker, E.L. Theunissen, S. Conen, K.P. Kuypers, W.K. Jeffery, H.C. Walls, G.F. Kauert, S.W. Toennes, M.R. Moeller, J.G. Ramaekers. A placebo-controlled study to assess Standardized Field Sobriety Tests performance during alcohol and cannabis intoxication in heavy cannabis users and accuracy of point of collection testing devices for detecting THC in oral fluid. Psychopharmacol. 2012, 223, 439.
25. S.W. Toennes, J.G. Ramaekers, E.L. Theunissen, M.R. Moeller, G.F. Kauert. Pharmacokinetic properties of delta9-tetrahydrocannabinol in oral fluid of occasional and chronic users. J. Anal. Toxicol. 2010, 34, 216.
26. M.M. Bergamaschi, E.L. Karschner, R.S. Goodwin, K.B. Scheidweiler, J. Hirvonen, R.H.C. Queiroz, M.A. Huestis. Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers' blood on per se drugged driving laws. Clin. Chem. 2013, 59, 519.
27. S. Anizan, G. Milman, N. Desrosiers, A.J. Barnes, D.A. Gorelick, M.A. Huestis. Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers. Anal. Bioanal. Chem. 2013, 405, 8451.
28. D. Lee, D.M. Schwope, G. Milman, A.J. Barnes, D.A. Gorelick, M.A. Huestis. Cannabinoid disposition in oral fluid after controlled smoked cannabis. Clin. Chem. 2012, 58, 748.
29. D. Lee, G. Milman, D.M. Schwope, A.J. Barnes, D.A. Gorelick, M.A. Huestis. Cannabinoid stability in authentic oral fluid after controlled cannabis smoking. Clin. Chem. 2012, 58, 1101.
30. G.F. Kauert, S. Iwersen-Bergmann, S.W. Toennes. Assay of Delta9-tetrahydrocannabinol (THC) in oral fluid-evaluation of the OraSure oral specimen collection device. J. Anal. Toxicol. 2006, 30, 274.
31. F. Grotenhermen, G. Leson, G. Berghaus, O.H. Drummer, H.P. Kruger, M. Longo, H. Moskowitz, B. Perrine, J.G. Ramaekers, A. Smiley, R. Tunbridge. Developing limits for driving under cannabis. Addiction 2007, 102, 1910.
32. J.M. Walsh, A.G. Verstraete, M.A. Huestis, J. Morland. Guidelines for research on drugged driving. Addiction 2008, 103, 1258.
33. C. Moore, C. Coulter, D. Uges, J. Tuyay, S. van der Linde, A. van Leeuwen, M. Garnier, J. Orbita Jr. Cannabinoids in oral fluid following passive exposure to marijuana smoke. Forensic Sci. Int. 2011, 212, 227.
34. C. Coulter, M. Garnier, C. Moore. Analysis of tetrahydrocannabinol and its metabolite, 11-nor-Delta(9)-tetrahydrocannabinol-9-carboxylic acid, in oral fluid using liquid chromatography with tandem mass spectrometry. J. Anal. Toxicol. 2012, 36, 413.
35. M.A. Huestis, A. Verstraete, T.C. Kwong, J. Morland, M.J. Vincent, R. de la Torre. Oral fluid testing: Promises and pitfalls. Clin. Chem. 2011, 57, 805.
36. D. Lee, G. Milman, A.J. Barnes, R.S. Goodwin, J. Hirvonen, M.A. Huestis. Oral fluid cannabinoids in chronic, daily cannabis smokers during sustained, monitored abstinence. Clin. Chem. 2011, 57, 1127.